AI is about to change healthcare. These 6 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Epson, the investment case rests on believing the company can turn its printing, imaging and document technologies into more resilient, higher-margin businesses while working through currently thin profitability and a rich earnings multiple. The National /AZON distribution deal and refreshed A3 scanners fit that story neatly: they extend Epson’s reach in professional imaging and document workflows, an area where its technology stack already looks strong, but they are unlikely to move near term revenue forecasts materially on their own. More important catalysts remain whether earnings can recover from recent one off impacts, how quickly margins stabilize, and how the upcoming Q1 2027 results on 5 August shape sentiment after a very strong share price run. Against that, dividend coverage, low return on equity and rising board turnover remain key risks.
However, investors should not ignore how fragile current margins and dividend coverage look today. Seiko Epson's shares have been on the rise but are still potentially undervalued by 29%. Find out what it's worth.Explore 2 other fair value estimates on Seiko Epson - why the stock might be worth 15% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com